managed dsip ii equity strategy Due Diligence in Private Equity: Safeguarding Deals Cross-Atlantic research agenda for scalable
Cross Atlantic research agenda for scalable grid architectures and distributed flexibility ScienceDirect Separating Apples from Pears The Hedge Fund Journal Reimagining the 60 40 Portfolio with Private Equity Secondaries A surprising deal from Vertex Pharmaceuticals adds to Big Pharma's acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

